Evaluating Novel ADC Payload Preclinical Characterisation to Set Up In-Human Translation for Success

• Laying out the hurdles for novel payload PK/PD characterisation without substantial historical data
• Breaking down novel payload ADME and PK/PD considerations for translation
• Understanding ideal attributes to observe to best set up next-generation payload translation for success

Speakers:

Niresh Hariparsad

Head, DMPK Boston, Oncology R&D

AstraZeneca